MELANIE AGNES MARIANO: Open Payments
NPI 1912677329 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,193 in 108 payments from 19 companies in 2025. Trend: 2023 $841 · 2024 $1,976 · 2025 $2,193
Food & beverage: $2,163Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $332 |
| Amgen Inc. | 14 | $243 |
| Abbott Laboratories | 14 | $242 |
| SANOFI-AVENTIS U.S. LLC | 7 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $166 |
| Insulet Corporation | 8 | $163 |
| Mannkind Corporation | 6 | $161 |
| Sequel Med Tech, LLC | 3 | $152 |
| Lilly USA, LLC | 5 | $97 |
| Ascendis Pharma Endocrinology Inc | 3 | $67 |
Products named: FREESTYLE LIBRE 3, TZIELD, Kerendia, Omnipod, AFREZZA, TWIIST, TEPEZZA, Ozempic.
Industry payments across NY — which companies pay providers there.
